Coiled-Coil Domain Containing Protein 124 Is a Novel Centrosome and Midbody Protein That Interacts with the Ras-Guanine Nucleotide Exchange Factor 1B and Is Involved in Cytokinesis by Telkoparan P. et al.
Coiled-Coil Domain Containing Protein 124 Is a Novel
Centrosome and Midbody Protein That Interacts with the
Ras-Guanine Nucleotide Exchange Factor 1B and Is
Involved in Cytokinesis
Pelin Telkoparan1, Serap Erkek1¤, Elif Yaman1, Hani Alotaibi1, Defne Bayık1, Uygar H. Tazebay1,2*
1 Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara, Turkey, 2 Department of Molecular Biology and Genetics, Gebze Institute
of Technology, Kocaeli, Turkey
Abstract
Cytokinetic abscission is the cellular process leading to physical separation of two postmitotic sister cells by severing the
intercellular bridge. The most noticeable structural component of the intercellular bridge is a transient organelle termed as
midbody, localized at a central region marking the site of abscission. Despite its major role in completion of cytokinesis, our
understanding of spatiotemporal regulation of midbody assembly is limited. Here, we report the first characterization of
coiled-coil domain-containing protein-124 (Ccdc124), a eukaryotic protein conserved from fungi-to-man, which we
identified as a novel centrosomal and midbody protein. Knockdown of Ccdc124 in human HeLa cells leads to accumulation
of enlarged and multinucleated cells; however, centrosome maturation was not affected. We found that Ccdc124 interacts
with the Ras-guanine nucleotide exchange factor 1B (RasGEF1B), establishing a functional link between cytokinesis and
activation of localized Rap2 signaling at the midbody. Our data indicate that Ccdc124 is a novel factor operating both for
proper progression of late cytokinetic stages in eukaryotes, and for establishment of Rap2 signaling dependent cellular
functions proximal to the abscission site.
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Introduction
Centrosomes are microtubule-organizing centers (MTOCs) that
play a key role in determining the geometry of microtubule arrays
in animal cells. They control and influence cell shape, polarity,
motility, spindle formation, as well as chromosome segregation
and cell division [1]. Each centrosome comprises a pair of
centrioles that are surrounded by an amorphous and dynamic
proteinaceous matrix referred to as the pericentriolar material
(PCM), which is considered to be the site where microtubule
nucleation initiates [2]. Associated with the multifunctional role of
this primary MTOC in the cell, the total amount of PCM
organized around centrioles (corresponding to centrosome size)
and the composition of PCM vary considerably throughout the
cell cycle [2–4].
Microtubule-nucleating capacities of centrosomes are increased
by recruitment of key PCM proteins such as c-tubulin and
gamma-tubulin complex proteins (GCP) forming the c-tubulin
ring complexes (c-tuRC), which orchestrate cell division-related
MTOC activities leading to the formation of spindle asters and
correct positioning of the two spindle poles. These cellular
activities are required for genetically stable cells as it facilitates
proper segregation of the duplicated chromosomes, ultimately
resulting in diploid daughter cells [4–7].
Recently, a number of efforts aimed to establish both the precise
composition of PCM at different stages of cell cycle, and the nature
of dynamic networks of molecular interactions that lead to
spatiotemporal regulation of PCM assembly. Jakobsen et al. [8]
have obtained an extensive coverage of human centrosome
proteome by using a mass spectrometry-based proteomics
approach combined with an antibody based subcellular screen of
candidate proteins [8]. In this study, the authors identified 126
known and 40 novel candidate centrosome proteins, of which 22
were validated as novel centrosome components, and 5 turned out
to associate preferentially either with mother or daughter
centrioles. These analyses also indicated that the majority (60%)
of centrosomal proteins contain coiled-coil domain (CCD) type
oligomerization motifs [8], [9], as their predominant structural
features, which seem to be important for proper centrosome
assembly.
Previous studies have indicated the presence of microtubule
nucleation-related proteins that are shared between the centro-
some and the midbody, which is the central region of the
intercellular bridge that is rich in anti-parallel microtubule bundles
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emanating from the central spindle [10]. These include for
instance c-tubulin, as the midbody is also a secondary MTOC
associated with the contractile ring forming at the site of cleavage
furrow ingression [1], [11]. Again, another protein with a CCD
motif, Cep55, is centrosomal in interphase cells, but dissociates
from the centrosome during entry into mitosis [12–14]. Precisely
at cytokinetic abscission Cep55 is localized to the midbody where
it plays an essential role in recruitment of the endosomal sorting
complex required for transport (ESCRT) components such as Alix
and tumor susceptibility gene 101 (tsg101, an ESCRT-I member),
as well as endobrevin (v-SNARE) [15–17]. This is then followed by
the recruitment of ESCRT-III components via interactions with
Alix and Tsg101, resulting in the translocation of CHMP4B to the
midbody [18]. According to current models, polymerization of
CHMP4B subunits forms series of cortical rings extending away
from the midbody, either as continuous helical contractile
filaments [18], [19] or to give rise to a second immediately distal
CHMP4B pool [20]. This then deforms the intercellular bridge
membrane neck into a narrow constriction, and subsequently
induces the abscission event.
Recent studies have also identified a number of factors other
than Cep55 that similarly localize to centrosomes early in mitosis
but then move to the midbody at cytokinesis where they execute
essential functions in fission of the daughter cells [10], [16].
Among those proteins, Polo-like-kinase-1 (Plk1) plays critical roles
in centrosome maturation and microtubule organization [7], [21],
[22]. At the midzone Plk1 also phosphorylates Cep55 on Ser-436,
thereby modulating its interaction with Mklp1, a kinesin-like
component of centralspindlin. This provides a temporal control of
abscission, by inhibiting functions of Cep55 in the midbody at
stages earlier than late-anaphase [23].
During our earlier studies on specificities of Ras-guanine
nucleotide exchange factor-1 (RasGEF1) family members [24],
we obtained preliminary evidences regarding possible interactions
between RasGEF1B and a previously uncharacterized protein
known as the coiled-coil domain-containing protein 124
(Ccdc124). Here, we report the first characterization of this
conserved human protein, Ccdc124, and show that it is a novel
component of the centrosome during interphase and at the G2/M
transition. During cell division, Ccdc124 relocates to the midbody
at telophase and acts as an essential molecular component in
cytokinesis. Ccdc124 interacts with RasGEF1B at the midbody
where this GEF could activate the small G protein Rap2 [24] at
pre-abscission stages. Our data propose a mechanistic link
between cytokinesis and Rap signaling that is mainly linked to
the formation of cell-cell junctions, regulation of cell-extracellular
matrix adhesion, and establishment of cell polarity [25], i.e.,
molecular processes that must follow cell division while tissues are
formed.
Results
Molecular Characterization of Ccdc124
The coiled-coil domain (CCD) is a motif that is found in most
centrosome proteins [8]. Intrigued by its strict conservation in all
eukaryotic genomes from fungi-to-man, we hypothesized that
CCDC124, a human gene of unknown function encoding a
putative CCD containing novel protein, could in fact be involved
in centrosome biology. We carried-out a comparative sequence
analysis on CCDC124 which encodes a cDNA that is transcribed
from chromosome 19p13.11, consisting of five exons, of which
exon 1 is non-coding. BLAST analysis indicated that the protein
encoded from this genetic locus shares, for instance, 70% identity/
89.1% similarity with its orthologue NP_956859 in the vertebrate
model Danio rerio (zebrafish), or 50.4% identity/72.6% similarity
with Y73E7A.1 in the invertebrate Caenorhabditis elegans. CCDC124
has also orthologues in lower eukaryotes such as the filamentous
fungus Aspergillus nidulans (AN0879.2; 35.1% identity/58.2%
similarity), or the fission yeast Schizosaccharomyces pombe
(SPBC29A10.12; 33% identity/57.8% similarity), while it is not
found in the budding yeast Saccharomyces cerevisiae.
Northern blot analysis have revealed that CCDC124 is
ubiquitously expressed in all tested human tissues, and relatively
high levels of expression were detected in the brain, placenta, liver,
spleen, and prostate (Fig. 1A). In these analyses, a transcript of
,1061 nucleotides was detectable in tested organs, in agreement
with the predicted size of CCDC124 mRNA in the NCBI databases
(http://genome.ucsc.edu), except in the placenta where we
observed a second shorter mRNA species indicative of a transcript
variant (Fig. 1A). CCDC124 cDNA would encode a protein of 223
amino acids with two putative coiled-coil domains between
residues 18–82 in the N-terminal half of the protein as detected
by the ELM (http://elm.eu.org) and COILS (www.ch.embnet.
org/software/COILS_form.html) bioinformatics analysis plat-
forms (Fig. S1). No significant homology to other proteins or
domains were found.
We generated a rabbit polyclonal antibody recognizing the
peptide corresponding to the N-terminal 24 amino acids of
Ccdc124 and characterized its specificity towards Ccdc124 in
immunoblots including peptide competition assays (Fig. 1B). We
identified Ccdc124 as a ,32 kDa protein in immunoblots using
different protein lysates obtained from Ccdc124 expression vector
(CMV-Ccdc124) transfected or untransfected human HEK-293
cells (Figs. 1B–C). Furthermore, when the Ccdc124 ORF was
tagged with an N-terminal flag-epitope in plasmid vectors, the
antibody also detected the flag-Ccdc124 at the expected size
(,35 kDa; Fig. 1C). When these bands were gel extracted and
subjected to peptide analyses by mass-spectrometry, the band of
,35 kDa were identified as the full-size flag-Ccdc124, suggesting
that without the flag epitope CCDC124 would encode a protein of
,32 kDa (Pelin Telkoparan, Lars A.T. Meijer, and Uygar H.
Tazebay, unpublished results). Surprisingly, anti-flag antibodies
failed to detect a similar robust band of ,35 kDa when the
epitope was inserted at the C-terminus, but instead they revealed a
band of ,32 kDa in lysates of cells transfected with vectors
expressing Ccdc124-flag (Fig. 1C). This indicated possible
proteolytic cleavage of the protein at its N-terminus when flag-
epitope is inserted to the C-terminus of Ccdc124. We have not
further characterized the proteolytic cleavage of this protein at the
molecular level, and we used the more stable N-terminus flag-
tagged Ccdc124 expressing vector (flag-Ccdc124) in the rest of our
studies.
Ccdc124 is a Novel Centrosome Protein Relocated to
Midbody at Telophase
In order to obtain insight into the biological function of
Ccdc124, we assessed the subcellular localization of endogenous
Ccdc124 by using generated or commercial anti-Ccdc124
antibodies in cellular immunofluorescence assays. When asyn-
chronusly growing HeLa cells were subjected to a preliminary
immunofluorescence analysis by using an anti-mid-Ccdc124
antibody recognizing the central part of the protein (between
residues 100–150), subcellular dot-like structures reminiscent of
centrosomal staining patterns were detected (results not shown, but
please see Fig. 2, below). We then synchronized the cells at G2/M
stage of the cell cycle by the MT polymerization inhibitor
nocodazole following double-thymidine treatments (Fig. S2, see
Methods s1), and followed cell cycle stage-dependent subcellular
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Figure 1. CCDC124 mRNA is ubiquitously expressed in human tissues, and it encodes a 32 kDa protein. (A) Hybridization of part of the
coding region of CCDC124 to an adult human multiple tissues Northern blot containing 2 mg of polyA-mRNA each lane. A single transcript of ,1061
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localization of endogenous Ccdc124 by immunofluorescence
assays using Ccdc124 N-terminal epitope (residues 1 to 24), mid-
region, or C-terminal epitope (residues 173 to 223)-specific
antibodies. Independent of the Ccdc124 antibody used, these
studies further indicated centrosome colocalization of Ccdc124
with c-tubulin at interphase, prophase, metaphase, and anaphase
stages, albeit it was relatively diffused to the pericentrosomal
region at anaphase (Fig. 2A). Similar results were obtained when
subcellular localization of an N-terminus flag-tagged version of
Ccdc124 was monitored by immunofluorescence stainings using
anti-flag antibodies on cells transfected with the corresponding
vector construct (Fig. 2B). Moreover, endogenous centrosome
immunostainings with anti-Ccdc124 Abs were very significantly
reduced in response to Ccdc124 depletion by esiRNAs targeting its
expression (see below, Fig. 4B), further supporting the notion that
Ccdc124 is a novel centrosome protein. Centrosome localization
of endogenous Ccdc124 was also observed in Retinal Pigment
Epithelial cells (RPE1) containing another centrosomal marker,
GFP-Centrin [26] (results not shown). Interestingly, at telophase
and in cytokinesis Ccdc124 dissociates from centrosomes and
relocalizes to the midzone, subsequently accumulating at the
midbody at cytokinesis as assessed by its colocalization with the
midzone-specific c-tubulin (Fig. 2A–B, and Fig. 3A, C), or by its
positioning at the midbody marked by the empty mid-space in a-
tubulin stainings (Fig. 3B). Immunofluorescence studies with
peptide competition assays further indicated that the Ccdc124
signal detected at the midbody was specific, as anti-N-ter-Ccdc124
antibodies pre-treated with the epitope peptide failed to recognize
Ccdc124 at the midbody (Fig. 3C).
Knock-down of CCDC124 by siRNAs Leads to Defects in
Cytokinesis
A number of midbody localized proteins were previously shown
to be involved in cytokinetic abscission [13], [16], [27]. In order to
test a possible role of Ccdc124 during the separation of dividing
sister cells, we initially knocked-down CCDC124 in HeLa cells by
separately transfecting them either with esiRNAs or with shRNA
vectors specifically targeting this gene. We first monitored knock-
down efficiencies by immunoblots that we carried-out using lysates
obtained from Ccdc124-specific esiRNA or shRNA vector
transfected cells as compared to scrambled esiRNA/shRNA
vector transfected controls. We observed approximately 75–80%
decrease in Ccdc124 levels in cells that received gene specific
esiRNAs as compared to scrambled transfected controls (Fig. 4A).
Again, depending on shRNA target sequence, close to 30–65%
decrease were detected in Ccdc124 levels in cells separately
transfected with three different sequences of shRNAs (Sh1, Sh2,
and Sh3), as compared to scrambled controls. In these assays,
Ccdc-Sh1 was identified as the vector containing the most potent
Ccdc124-targeting shRNA sequence (Fig. 4A) We then analyzed
cellular morphologies, centrosome localizations, and midbody
functions of asynchronous growing cells that received either
Ccdc124 specific esiRNAs, or shRNA vectors targeting the same
gene. In Ccdc124-depleted cells interphase centrosomes still
formed, as assessed by immunostainings that mark c-tubulin
complexes (Fig. 4B). This indicated that the absence of Ccdc124
does not impair centrosome formation. However, in Ccdc124-
depleted cells cytokinesis was remarkably blocked as assessed by
the significantly increased percentage of bi- and multinucleated
cells (Fig. 4C–D) from 2.560.3% in scrambled control esiRNA
transfected cases to 14.661.5% in Ccdc124-specific esiRNA
received asynchronous cultures (Fig. 4C). The percentage of
multinucleated cells in Ccdc124-depleted cultures were decreased
significantly and nearly restored to normal levels (4.560.8%) when
Ccdc124 was reintroduced in a strong expression vector (Fig. 4A,
C). This indicated that the cytokinesis defect observed with the
esiRNA against Ccdc124 was specific. Further supporting this
observation, the ratio of multinucleated cells also raised from
3.160.2% in scrambled shRNA vector received cells to
11.662.7% in cells transfected with Ccdc-Sh1 (Fig. 4B), indicating
that defects in cytokinesis was specific to endogenous Ccdc124
depletion in HeLa cells rather than an off-target effect of RNAi.
Identification and Characterization of Interaction Partners
of Ccdc124
In order to identify possible interaction partners of Ccdc124, a
human liver cDNA library was screened in a yeast two-hybrid
assay system as described in Materials and Methods. Colonies with
interacting partners were selected, and the corresponding prey
fragments were sequenced at their 59 and 39 junctions. All 15
positive colonies contained overlapping cDNA sequences belong-
ing to only one gene, RasGEF1B, suggesting that this guanine
nucleotide exchange factor (GEF) is a strong candidate as an
interaction partner of Ccdc124. RasGEF1B was first identified in
zebrafish as a protein expressed in neural cells during late
embryogenesis and early larval stages [28]. Furthermore, by using
in vitro assay systems [24] we previously characterized RasGEF1B
as an exchange factor exclusively activating the small G protein
Rap2. RasGEF1B was also identified in murine macrophages as a
toll-like receptor inducible protein with a subcellular localization
in early endosomal vesicles [29].
Following the yeast two-hybrid assays, we were able to confirm
the interaction between Ccdc124 and RasGEF1B, first by in vitro
GST pull-down methods (Fig. 5A), and then by analyzing their
association in mammalian HEK-293 cells transfected with flag-
Ccdc124 and GFP-RasGEF1B containing expression vectors
(Fig. 5B). Coimmunoprecipitation of GFP-RasGEF1B and flag-
Ccdc124 in transfected cells could indicate a functional interaction
between these two proteins. In parallel to functional studies to
establish cellular roles of Ccdc124 and RasGEF1B, we sought to
determine whether the subcellular localizations of these two
proteins were comparable throughout the cell cycle. In fact, in a
previous study, RasGEF1B was shown to localize in endosomal
vesicles when fluorescent protein-fused versions (YFP-RasGEF1B
or mRFP-RasGEF1B) were ectopically expressed in asynchronous
CHO cells [29]. However, the subcellular localization of
RasGEF1B was not previously addressed in cell cycle-synchro-
nized cells. Identification of an endosomal vesicle factor such as
nucleotides was detectable in all human tissues analyzed, except the placenta with a second smaller transcript variant. The same blot was
rehybridized with probes corresponding to two differentially expressed genes, b-actin and GAPDH, to monitor blotting quality. (B) Specific detection
of ectopically expressed Ccdc124 by anti-Ccdc124 antibodies. HEK-293 cells, either non-transfected, or transfected with CMV-promoter controlled
Ccdc124 were lysed, protein lysates were separated by SDS-PAGE, and immunoblot was performed either with anti-Ccdc124 antibodies alone, or
same antibodies pre-incubated with 100 ng of competing peptide epitope corresponding to N-terminus 24mer peptide of Ccdc124. (C) Expression of
Flag-tagged Ccdc124 protein was specifically detected by the anti-Ccdc124 or with anti-Flag antibodies, as indicated. Asterisk (*) indicates C-terminus
flag-tag insertion dependent N-terminus cleaved form of Ccdc124. The expression of calnexin was confirmed in all cell lysates as an equal loading
control.
doi:10.1371/journal.pone.0069289.g001
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Figure 2. Ccdc124 is present at the centrosome and it concentrates at the midbody in late stages of cytokinesis. (A) HeLa cells were
arrested at G2/M phase by sequential double thymidine and nocodazole treatments, then the drug was washed-off, cells were analyzed by
immunofluorescence at time points with intervals of 15 minutes, and they were classified according to phases of mitosis, and cytokinesis. Samples of
cells were then costained with anti-Ccdc124 and anti-c-tubulin antibodies, and in interphase and prophase, Ccdc124 was observed as puncta in cells,
Ccdc124 Is Involved in Cytokinesis
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RasGEF1B as an interaction partner of centrosomal and/or
midbody localized Ccdc124 is particularly interesting, as critical
roles of endosomes in physical separation of cells during
cytokinetic abscission are well established in recent studies (for a
review, see [30]). Subsequently, we generated a rabbit polyclonal
antibody recognizing the C-terminal 19 amino acids epitope of the
Zebrafish orthologue of RasGEF1B, and by immunoblotting
analysis we first established that it also recognizes the human
RasGEF1B protein (Fig. S3). Then, by using this antibody, we
observed that even though in HeLa cells at interphase and
prophase it displays characteristics of previously suggested
cytoplasmic/early endosome localization [29], in metaphase cells
RasGEF1B was located at a pericentrosomal/centrosomal posi-
tion, as assessed by its co-localization with c-tubulin, a subcellular
localization similar to that Ccdc124 at metaphase cells (Fig. 6A,
compare with Fig. 2).
Again similar to Ccdc124, at telophase and during cytokinesis
RasGEF1B was detected at the midzone and in the midbody, and
the RasGEF1B immunostaining at the midzone/midbody was
sensitive to shRNAs (Fig. S4) targeting the expression of this GEF
(Fig. 6B–C), indicating that the immunofluorescence signal was
specific to the midbody localized RasGEF1B. Furthermore, during
late stages of cytokinesis GFP-tagged RasGEF1B localized to the
midbody as described for the endogenous protein (Fig. 6D).
Noticeably, in these cell assays GFP-RasGEF1B clearly colocalized
with Ccdc124 at the midbody puncta, suggesting that in late-
cytokinesis the midbody forms a site of interaction for the two
proteins. These results imply a possible role of Ccdc124 in linking
cytokinesis to previously uncharacterized RasGEF1B dependent
signaling at the midbody. As a note, we observed that bacteria
purified Ccdc124 does not functionally interfere with the guanine
nucleotide exchange activity of RasGEF1B in in vitro reconstituted
assay systems (see below, Elif Yaman, Alfred Wittinghofer, and
Uygar H. Tazebay, unpublished results), suggesting that Ccdc124
could affect spatial regulation of RasGEF1B, rather than
modulating its GEF activity.
RasGEF1B Stimulates Guanine Nucleotide Exchange of
Rap2 in Mammalian Cells in Culture
Activation cycle of small G proteins is regulated by guanine
nucleotide exchange factors (GEFs), which induce dissociation of
bound GDP and its replacement by the more abundant GTP, and
the resulting conformational change allows the binding of effector
proteins and thereby stimulation of downstream signaling.
Previous functional studies by Yaman et al. [24] indicated that
under in vitro conditions RasGEF1B specifically activates Rap2 by
stimulating guanine nucleotide exchange only of this small G
protein, whereas it does not activate even its close family member,
Rap1, or other members of Ras family. We decided to take these
in vitro studies to one level up, and confirm the stimulatory effect of
RasGEF1B on Rap2 GDP/GTP nucleotide exchange by knock-
ing-down this GEF in HEK-293 cells, followed by assessing GTP-
bound active Rap2 (Rap2.GTP) status in these cells. For this, we
used a Rap-activity assay method based on immunoprecipitation
of active Rap proteins by the Rap-binding domain of RalGDS
(RBD-RalGDS), as previously described [31]. When RasGEF1B is
knocked-down to nearly 55% in HEK-293 cells by specific down-
regulatory shRNA-containing vectors (Fig. S4), significantly less
Rap2.GTP were present in cells, even though total Rap2 amounts
were not affected (Fig. 7). This indicated a functional link between
RasGEF1B and Rap2 GTP-binding protein activation in this cell
system. These results were consistent with our previous in vitro
studies that established Rap2 as the sole RasGEF1B activated Ras-
family GTP-binding protein [24].
Active Rap2 GTP-binding Protein is Relocated to the
Midbody at Cytokinesis
We then decided to assess if RasGEF1B substrate G protein
Rap2 was also located in centrosomes and midbody during
different stages of cell cycle. Our data indicated that at the
midbody the position of Rap2 overlapped both with RasGEF1B
and with Ccdc124 in binary comparisons (Fig. 8A, B). Depletion of
endogenous Rap2 in HeLa cells by transfecting them with Rap2-
specific shRNA vectors have led to the loss of endogenous Rap2 at
the midbody (Fig. 8C, D). However, depletion of Rap2 did not
result in a significant increase in percentages of multinucleated
cells above scrambled controls (Fig. 8C, D). This result could
suggest that although Rap2 is located at the midbody, its
molecular function(s) at this organelle is(are) not essential for
proper completion of cytokinesis. Subsequent immunofluorescence
assays using anti-Rap2 antibodies on dividing HeLa cells indicated
that Rap2 migrates to the midzone during anaphase/telophase
(Fig. 9A, B), which is in contrast to its homologue Rap1 that is
non-responsive to RasGEF1B [24] (Fig. S5). We also observed that
in synchronously dividing cells 90 mins after they were released
from nocodasole, at initial stages of cytokinesis Rap2 associates
with microtubules originating at the midzone, and it migrates to
the very center of intercellular bridge (boundaries marked with a-
tubulin, Fig. 9B), relocating itself to midbody during cytokinetic
abscission (Fig. 9A, B).
We then inquired whether Rap2 located at the midbody was
functionally active during cytokinetic abscission, by transfecting
HeLa cells with a GFP-labeled recombinant version of the Rap
Binding Domain (RBD) of RalGDS referred as GFP-
RBD(RalGDS). This GFP-labeled effector protein interacts with
Rap2 specifically in the GTP-bound active state of the G protein,
and thus serves as a subcellular Rap2 activity reporter [32]. When
the signal coming from the GFP-RBD(RalGDS) that interacts with
Rap2.GTP was followed at the subcellular level, at the interphase
both endogenous Rap2 and GFP-RBD(RalGDS) were detected to
localize diffusely at the cytoplasm with only a partial overlap
(Fig. 10A, interphase). However, during cytokinetic abscission,
GFP-RBD(RalGDS) very clearly colocalized with Rap2 at the
midbody, indicating that Rap2 protein identified at the spindle
midzone/midbody is in its GTP-bound active form (Fig. 10A,
cytokinesis), and that it may potentially act on its specific effectors
at this location. Midbody localization of GFP-labeled
RBD(RalGDS) strictly depended on the presence of an active
Rap2, as in cells co-transfected with dominant negative version of
Rap2 (Rap2-S17N) the reporter protein GFP-RBD(RalGDS) did
not relocate with the same efficiency to the midbody during
cytokinesis as compared to cells transfected with wild-type Rap2
(Fig. 10B). The endogenous activation of local Rap2 signaling at
midbody did not require pretreatment of cells with secondary
messengers such as cAMP, diacylglycerol (DAG), or calcium that
were previously shown to stimulate Rap signaling through
and it is located in the MTOC area. In metaphase and anaphase cells, Ccdc124 appeared at the spindle poles. Ccdc124 was present at the midzone
and at the spindle poles in late anaphase, and concentrated in the midbody during cytokinesis. (B) HeLa cells were transfected with the N-ter flag-
Ccdc124 vector construct as in Figure 1. 48 hours later samples of cells were subjected to immunofluorescence costainings using anti-flag and anti-c-
tubulin Abs together. Representative micrographs of cells at different stages of cell cycle are given. Bars represent 10 mm.
doi:10.1371/journal.pone.0069289.g002
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activation of various GEFs [33], [34]. This indicate that the
recruitement of RasGEF1B to the midbody could be sufficient for
regulation of Rap2 activity, as well as for translocation of Rap2
effectors to this subcellular location.
Conclusion and Discussion
Previous biochemical studies and mass-spectrometry analyses on
purified centrosomes have shown that proteins with CCD (coiled-
coil domain) motifs are abundant in PCM [8], [35]. Close to 150
different proteins were identified in the PCM at different cellular
stages, about 60% of which contain predicted CCD type
oligomerization motifs [8]. In this work, by using molecular and
cell biology methods we identified Ccdc124 as a novel component
of the centrosome, as in cells at interphase and in mitotic cells up
to the late-anaphase/telophase stage it clearly colocalized with two
different centrosome markers, such as c-tubulin and centrin (Fig. 2,
and unpublished data). Despite multiple high throughput
proteomics analyses targeting centrosome composition in the past,
Ccdc124 was not in the list of PCM proteins prior to this study,
indicating that combined genetic, cell biology and biochemical
approaches are still necessary to identify all the components of
PCM which has a remarkably dynamic composition [1], [36].
Conservation of Ccdc124 in lower eukaryotic species without
centrosomes, such as A. nidulans, or S. pombe was not surprising, as
also some major centrosome proteins (for instance, c-tubulin) were
common between this organelle and fungal spindle pole bodies
[37]. The absence of an orthologue of Ccdc protein in S. cerevisiae,
however, might indicate that Ccdc124 is not essential for fungi
with budding-type of cell division.
Our data revealed that at late-anaphase/telophase stages of cell
cycle Ccdc124 changes its subcellular localization: it dissociates
from centrosomes, and first relocalizes to the midzone at late-
anaphase, and then it accumulates at the midbody puncta at
telophase and during cytokinetic abscission (Fig. 2–4). Currently,
we do not know what triggers the displacement of Ccdc124 from
Figure 3. Ccdc124 accumulates at the midbody. HeLa cells were synchronized as described in the legend of Fig. 2, and samples of cells were
then stained with anti-Ccdc124 Ab together either with anti-c-tubulin or with anti-a-tubulin Abs to monitor subcellular positions of centrosomes and
the midbody. (A–B) At telophase and cytokinesis Ccdc124 is observed as puncta typically associated with the midbody positioned at the middle of
intercellular bridge separating daughter cells, as detected in costainings with anti-c-tubulin and anti-a-tubulin Abs, respectively. (C) Peptide
competition assays were done by pre-incubating anti-N-ter-Ccdc124 antibody with the corresponding epitope peptide in 200-fold molar excess
amounts. Signals generated by Ccdc124 localized at the midbody (shown with arrowhead) were lost in immunofluorescence assays where peptide
pre-treated antibodies were used. Bars represent 10 mm.
doi:10.1371/journal.pone.0069289.g003
Figure 4. Depletion of Ccdc124 in HeLa cells by RNAi leads to cytokinesis failure. (A) HeLa cells were transfected with either esiRNAs or
shRNA vectors (Sh1, Sh2, Sh3) targeting Ccdc124, cell lysates were collected at 48 hrs post-transfection, and immunoblotted with antisera to
Ccdc124. Where indicated, Ccdc124 expression vector (CMV-Ccdc124) was cotransfected with gene-specific esiRNAs in order to rescue the cellular
effect of Ccdc124 depletion. Scrambled control transfections were indicated (Scr). Calnexin expression was monitored as loading control. (B)
Immunostainings of endogenous Ccdc124 in cells transfected with Ccdc124-specific esiRNA, or with scrambled control esiRNA were carried out with
anti-Ccdc124 Ab. Costainings with c-tubulin antisera have indicated subcellular positions of MTOCs (C) Cells described and analyzed in (A) were
scored for bi- and multinucleation (n = 56 SD). (D) Representative micrographs of Ccdc124 depleted multinuclear or control esiRNA treated normal
dividing cells described in (C). Bars represent 10 mm.
doi:10.1371/journal.pone.0069289.g004
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the centrosome, or its association to the midzone/midbody. In
fact, Cep55, a relatively well studied coiled-coil containing
centrosome protein that relocates to the midbody and controls
cytokinetic abscission, was shown to be a substrate of Plk1 [13].
Phosphorylation of Cep55 by Plk1 on its Ser436 residue is
required for its interaction with centralspindlin and ESCRT
complex proteins, leading to the recruitment of CHMP4B to the
midbody [13], [16]. This is then followed by the assembly of this
ESCRT-III component into a series of ring-like structures
organizing the abscission site, mainly by bringing the two
membranes of the intercellular bridge into close proximity for
the scission [20], [38]. Even though in the current study we have
not addressed post-translational modifications of Ccdc124, there
are several reasons why we anticipate that its functions/stability
could be regulated by phosphorylation dependent mechanisms.
First, Ccdc124 is identified as a phosphoprotein in our preliminary
phosphopeptide analysis by mass-spectrometry methods, and
Ser141 residue of Ccdc124 (which is a consensus Plk1 phosphor-
ylation site) was detected as a phosphorylated residue (Pelin
Telkoparan, Lars A.T. Meijer, and Uygar H. Tazebay, unpub-
lished results). Second, when we mutated predicted Ser, Thr, or
Tyr phosphorylation sites to Ala residues in Ccdc124 by in vitro
mutagenesis, the Ser121 residue conforming to a Casein Kinase-II
phosphorylation consensus site turned out to be essential for the
stability of Ccdc124 protein, even though phospho-mimicking
mutations S121D, and S121E were normal in terms of protein
stability (Fig. S6A, B), indicative of possible phosphorylation
dependent regulatory mechanisms operating on Ccdc124.
We found that Ccdc124 depleted cells can still form MTOC,
but they undergo cytokinesis failure inducing aneuploidy and
generating genomic instability in cultured human cells (Fig. 4).
According to current models of cytokinetic abscission, resolution of
the membrane connection between two prospective daughter cells
requires a concerted action of ESCRT proteins together with the
targeting of three main types of recycling endosomes to midbody
for an appropriate regulation of cytokinetic abscission (see below)
[39], [40]. In an early work, Gromley et al, proposed a role for
secretory vesicle fusion in the final stages of cytokinetic abscission,
as they have shown that the coiled-coil protein centriolin relocates
to midbody where, preceding abscission, it interacts with
components of vesicle-targeting exocyst complexes and mem-
brane-fusion inducing SNARE components [11]. However,
subsequent studies indicated that even though the secretary
pathway could contribute to formation of the intracellular bridge
membrane, it is rather recycling endosome-dependent mecha-
nisms that make major contributions to spatiotemporal regulation
of cytokinetic abscission [40]. Furthermore, other than two Ral
family G proteins RalA and RalB, endosome enriched complexes
such as Rab35/OCRL and FYVE-CENT/TTC19 that were
found on different types of endosomes, were previously shown to
enable the completion of the final stages of abscission [41–43].
Our data suggested possible links between Ccdc124 and recycling
endosomes. First, we identified an endosome localized nucleotide
exchange factor RasGEF1B [29] as an interaction partner of the
coiled-coil protein Ccdc124 (Fig. 5–6). Second, RasGEF1B
activated small G protein Rap2 that we detected at the
midzone/midbody, was previously reported to colocalize with
Rab11-positive endosomes in Xenopus early embryos [44]. Impor-
tantly, Rab11-positive recycling endosomes containing the effector
protein FIP3 (Rap11 Family of Interacting Protein 3) were
previously shown to control the reorganization of the cortical
actomyosin network during cytokinetic abscission, as they accu-
mulate at the intercellular space between dividing cells and
regulate local actin depolymerization by recruiting p50RhoGAP,
and thus contributing to further thinning of the bridge [45].
In this study, we primarily focused on the biological significance
of the interaction between Ccdc124 and RasGEF1B, rather than
studying mechanistic aspects of it. Yet, our studies on the effect of
bacteria purified Ccdc124 on the rate of nucleotide exchange by
RasGEF1B on Rap2A in in vitro reconstituted assay systems
suggested that Ccdc124 does not functionally interfere with
RasGEF1B activity (Elif Yaman, Alfred Wittinghofer, Uygar H.
Tazebay, unpublished observations). We could hypothesize that
rather than modulating its GEF activity, Ccdc124 could recruit
Figure 5. RasGEF1B is an interaction partner of Ccdc124. (A) In vitro GST pull-down assay indicating a possible interaction between RasGEF1B
and Ccdc124. GST-RasGEF1B protein were immobilized on GSH-beads, followed by incubation with empty PBS buffer control (lane 1), or with bacteria
purified His-tagged Ccdc124 (lane 2). As controls, GSH-beads w/o RasGEF1B protein incubated with His-Ccdc124 to monitor the amount of His-
Ccdc124 proteins binding to GSH-beads in the absence of a putative interaction partner (lane 3), or GSH-beads immobilized with GST protein and
incubated with His-Ccdc124 to monitor interaction capacity of Ccdc124 with GST (lane 4). Lanes 5, 6, 7 are stainings of 100 ng bacteria purified GST-
RasGEF1B, His-Ccdc124, and GST proteins, respectively, run in the same gel to monitor their corresponding sizes. Bands corresponding to His-
Ccdc124 were marked with asterisks (*). (B) HEK-293 cells were either transfected with Flag-Ccdc124 or GFP-RasGEF1B expression vectors alone or
with indicated control plasmids, or alternatively they were co-transfected with Flag-Ccdc124 and GFP-RasGEF1B together, followed by
immunoprecipitations (IP) on cell lysates using protein-G beads with anti-Flag antibodies. Subsequently, immunoblots were done on IP or cell
lysate samples using anti-GFP (monitoring GFP-RasGEF1B) or anti-Flag-HRP (to assess Flag-Ccdc124) antibodies.
doi:10.1371/journal.pone.0069289.g005
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RasGEF1B to midzone/midbody where the exchange factor
activate its substrate G protein(s). A similar spatiotemporal
regulation of Rap1 signaling localized at the plasma membrane
by recruitement and translocation of its cAMP responsive GEF,
Epac1, through activation of Ezrin-Radixin-Moesin (ERM)
complex proteins was previously described [46].
We have shown that both the activator RasGEF1B and its
partner G protein Rap2 have identical spatiotemporal subcellular
distributions (Fig. 8). This indicated that RasGEF1B could
potentially activate GDP/GTP exchange of Rap2 at midbody
during late-telophase stage of cell cycle and at cytokinesis.
Importantly, we observed the RasGEF1B substrate Rap2, but
not its close homologue Rap1, accumulated in vesicular structures
proximal to the midzone and at the midbody (Fig. 9A, see panels
metaphase to cytokinesis, and Fig. S5). Detection of active Rap2
(Rap2.GTP) binding reporter protein GFP-RBD(RalGDS) in
midbody further proved local activation of Rap2 at midbody
puncta during cytokinesis (Fig. 10). This midbody localization of
GFP-RBD(RalGDS), was only observed in cells having Rap2-WT,
but not its dominant negative form, Rap2-S17N, indicating that
midbody localization of Rap2 effectors requires activation of this
small G protein (Fig. 10B). Neither cellular depletion of
endogenous Rap2 by specific shRNA transfections, nor over-
expression of the dominant negative form of Rap2 (S17N) has led
to cytokinesis defects, as assessed by normal levels of bi- and
multinucleated cells in corresponding cellular assays (Fig. 8, 10).
Therefore, in our opinion rather than playing a direct role in
cytokinesis, localization of Rap2 at the midbody might serve to
modulate and/or functionalize local membrane environment for
molecular events following cytokinetic abscission, such as estab-
lishment of cell-cell junctions, cell-extracellular matrix adhesions,
or polarizations of cells after division of daughter cells fully
accomplished. When we consider results obtained in this study
altogether, we propose Ccdc124 as a novel factor that links
cytokinesis to Rap signaling dependent junction/adhesion or
cellular polarization promoting molecular mechanisms, thus
bonding different cellular events that must closely follow each
other in tissues of live organisms.
Figure 6. RasGEF1B and Ccdc124 colocalize at the midbody. (A–B) Subcellular localizations of RasGEF1B proteins in synchronously dividing
HeLa cells were detected with specific anti-RasGEF1B antibodies. Cell divisions were synchronized as described in the legend of Figure 2, above.
Representative immunofluorescence microscopy images of HeLa cells costained with anti-RasGEF1B, and either anti-c-tubulin (A) or a-tubulin (B)
antibodies illustrating the position of MTOCs and the midbody at cytokinesis. Arrowheads show RasGEF1B detected at the midzone and the
midbody. (C) Immunofluorescence signals observed at midbody were significantly decreased when endogenous RasGEF1B were depleted by
transfections with specific shRNA vectors (Sh-C or Sh-D, Fig. S4) and representative micrographs were shown. (D) HeLa cells transiently transfected
with GFP-RasGEF1B were fixed and stained using anti-Ccdc124 Abs. Arrowheads indicate midbody positions of GFP-RasGEF1B, Ccdc124, and their
colocalizations at the midbody. Bars represent 10 mm.
doi:10.1371/journal.pone.0069289.g006
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Methods
Ethics Statement
All cell lines of human origin used in this study were obtained
legally either from commercial sources, or they were previously
published. Material transfer agreements were duly signed between
appropriate offices/persons-in-charge at donating and receiving
institutions.
Cell Culture and Reagents
Hek-293 and HeLa cells were maintained in DMEM and
Retinal Pigment Epithelial-1 (RPE1) cells were grown in DMEM/
F12 (1:1) supplemented with 10% FBS and kept at 37uC in a
humidified 5% CO2 atmosphere. Cell lines used in this work were
either from commercial sources, or described in previous
publications. RPE1 cells [26] were obtained from Nurhan Özlü
(Koç University, Istanbul), and RPE1 lines stably expressing GFP-
Centrin [26], and GFP-Plk1 [47] were gifts from Greenfield
Sluder (U. Mass. Medical School, MA), and Prasad Jallepalli
(Memorial Sloan-Kettering, NY), respectively. 50 nM of MissionH
esiRNA from Sigma-Aldrich (cat. EHU004061) was used for
silencing Ccdc124 in HeLa cells by using Oligofectamine
(Invitrogen) as transfection reagent. We have also targeted
Ccdc124 expression by using the following three shRNA vector
constructs prepared in pTRIPZ plasmids (Open Biosystems-
Thermo) closely following the procedures described by Paddison
et al. [48]. Ccdc124 specific shRNA sequences inserted in pTRIPZ
vectors were as follows: shRNA #1: 59-TGCTGTTGACAGT-
GAGCGACTCGACCAGCTGGAACGTAA|GTAGT-
GAAGCCACAGATGTACTTACGTTCCAGCTGGTC-







TACTGCCTCGGA-3. pTRIPZ vector containing scrambled
shRNA control were purchased (Open Biosystems-Thermo, cat.
no. RHS4750). In experiments to rescue cellular effects of
Ccdc124 knock-downs by specific esiRNAs, 40 ng of pCDN3.1-
CMV-Ccdc124 plasmids were cotransfected with the above
indicated amounts of esiRNAs. In order to knock-down Ras-
GEF1B expression, a set of five plasmids containing shRNA
sequences specific for human RasGEF1B gene in pLKO1 vectors,
and the corresponding scrambled shRNA control plasmid were
purchased (Open Biosystems-Thermo) with the catalog number
RHS4533 (TRC Lentiviral shRNAs) and following sequences: 1)
Oligo ID: TRCN0000072963, 59-CCGGGCTGACAGATA-
GACTCAGATTCTCGAGAATCTGAGTCTATCTGT-
CAGCTTTTTG-39, renamed as sh-A; 2) Oligo ID:
TRCN0000072964, 59-CCGGCGGAAACATTTCCCTAT-
GATTCTCGAGAATCATAGG-
GAAATGTTTCCGTTTTTG-39, renamed as sh-B; 3) Oligo ID:
TRCN0000072965, 59-CCGGCGGTTATTTATGCATCCG-
TATCTCGAGATACGGATGCATAAATAACCGTTTTTG-
39, renamed as sh-C; 4) Oligo ID: TRCN0000072966, %’-
CCGGGCTCTCTACTTGGCTTCTTATCTCGAGATAA-
GAAGCCAAGTAGAGAGCTTTTTG-39, renamed as sh-D; 5)
Oligo ID: TRCN0000072967, 59-CCGGGAAGCACTCATC-
CAGCACTTACTCGAGTAAGTGCTGGAT-
GAGTGCTTCTTTTTG-39, renamed as sh-E. Similarly, for
decreasing Rap2 expression, a set of three plasmids containing
shRNA sequences specific for human Rap2 gene in pGIPZ
vectors, together with the corresponding scrambled shRNA
control vector were purchased (Open Biosystems-Thermo) with
the catalog number RHS4531 (TRC Lentiviral shRNAs) and








as sh-2; 3) Oligo ID: V2LHS_34662, 59-TGCTGTTGACAGT-
GAGCGCTGACCTTGTGTCACTATTTATTAGTGAAGC-
CACAGATGTAATAAATAGTGACACAAGGTCAATGCC-
TACTGCCTCGGA-39, renamed as sh-3. When indicated, cells
were synchronized by a first thymidine block (2,5 mM) for 16
hours, released for 8 hours, and then blocked a second time with
thymidine for 16 hours, followed by 200 nM nocodasole
treatment/12 hours. Mitotic arrested cells were collected by
‘‘mitotic shake-off’’, and either they were analyzed directly
(0 min.), or recultured for 15, 30, 45, 60, 120, 150, and 180 mins.
At the beginning of the experiments cell cycle status of samples
were established by FACS analysis as described in Fabbro et al.
[13] and at each time point cells were processed for immunoflu-
orescence.
Figure 7. The guanine nucleotide exchange factor RasGEF1B
controls cellular Rap2.GTP status. HEK-293 cells were transfected
either with RasGEF1B specific shRNA expressing vector (Sh-D, Figure
S4), scrambled shRNA expressing vector, or empty vector (negative
control), 48 hrs later cells were lysed as described at Materials and
Methods, they were cleared by centrifugation, and active Rap was
precipitated with a glutathione S-transferase fusion protein of the Ras-
binding domain of RalGDS precoupled to glutathione-Sepharose beads.
Rap2 activation assay were carried-out by using anti-Rap2 monoclonal
Abs. Results confirmed that shRNA mediated down-regulation of
RasGEF1B expression effectively block generation of Rap2.GTP,
although total cellular Rap2 was not affected. Calnexin expression
was monitored as loading control.
doi:10.1371/journal.pone.0069289.g007
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Vector Constructions
pCDNA3.1 was used to generate CMV-promoter controlled
Ccdc124 expression vector construct by using EcoRI/BamHI
restriction sites and 59-AAGCTTGAATTCATGCCCAA-
GAAGTTCCAGGGTGAG-39 (forward) and 59-GGTACCGG-
GATCCTCTTGGGGGCATTGAAGGGCAC-39 (reverse)
primers. Cloning of RasGEF1B into pEGFP-C1 (Clontech) was
done by using 59- GTCGACGAATTCTTAAACTCTGCCTAA-
GAGGCTCGACC-39 (forward), and 59-GTCGACGAATTCT-
TAAACTCTGCCTAAGAGGCTCGACC-39 (reverse) primers
and XhoI/EcoRI sites. Flag-tagged Ccdc124 expressing vectors
were constructed by sub-cloning the gene in p3X-Flag-CMV10 or





GAGTCCTTGGGGGCATTGAAG-39 (reverse) primers togeth-
er with EcoRI/BamHI, and EcoRI/XbaI restriction enzyme sites,
respectively. HA-epitope linked versions of Rap2 in Rap2-WT-
HA, Rap2-G12V-HA, and Rap2-S17N-HA vectors were kind
gifts of Daniel Pak (University of California, Berkeley). GFP-
RBD(RalGDS) expression vector was a gift from Johannes L. Bos
(University Medical Center Utrecht, the Netherlands).
Rap Activity Assays
Rap activity assays were carried-out as described previously by
van Triest and Bos [31]. Briefly, HEK-293 cells grown in 6-cm
plates were lysed in buffer containing 1% NP-40, 150 mM NaCl,
50 mM Tris-HCl (pH 7.4), 10% glycerol, 2 mM MgCl2, and
protease and phosphatase inhibitors. Lysates were cleared by
centrifugation, and active Rap was precipitated with a glutathione
S-transferase fusion protein of the Rap-binding domain of
RalGDS precoupled to glutathione-Sepharose beads.
Figure 8. Rap2 colocalize with Ccdc124 and RasGEF1B at the subcellular level. Subcellular localizations of endogenous Rap2 and Ccdc124
or RasGEF1B proteins were studied in HeLa cells by immunofluorescence methods. (A) At anaphase, Rap2 was clearly localized at the midzone, while
Ccdc124 concentration at the same localization was less pronounced. However, at telophase, both proteins were concentrated at the puncta
characterizing the midbody, Rap2 rather surrounding Ccdc124. During cytokinetic abscission, a clear colocalization of both Rap2 and Ccdc124 were
observed at the midbody. (B) Similar to panel (A), Rap2 translocation to the midzone has started during anaphase. Two representative images of
anaphase cells were shown in the corresponding panel. Both Rap2 and RasGEF1B proteins colocalized at the midbody during cytokinetic abscission.
Arrowheads either indicate subcellular localization of Rap2 at anaphase and telophase, or they indicate the colocalization of Rap2 with RasGEF1B/
Ccdc124 at the midbody during cytokinesis. (C) HeLa cells were transfected with shRNA vectors (Sh1, Sh2, Sh3) targeting Rap2, then cell lysates were
collected at 48 hrs post-transfection, and immunoblotted with anti-Rap2 Ab. Scrambled control transfection was indicated (Scr). Calnexin expression
was monitored as loading control. In parallel experiments, similarly treated cells were immunostained with anti-Rap2 and anti-a-tubulin antibodies,
followed by scorings for multinucleation (n = 56 SD), as reported on the graph above the immunoblot. (D) Representative micrographs of midbody
stage cells depleted in endogenous Rap2 (C). Bars represent 10 mm.
doi:10.1371/journal.pone.0069289.g008
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Figure 9. Active endogenous Rap2 relocates to midzone at anaphase, and to midbody during cytokinetic abscission. (A) HeLa cells
were arrested at G2/M phase by sequential double thymidine and nocodazole treatments as described in the legend of Figure 2, and they were
classified according to phases of mitosis, and cytokinesis. Samples of cells were then stained with anti-Rap2 antibody, and with DAPI to visualize DNA.
At anaphase Rap2 was detected at the midzone with staining characteristics reminiscent of endosomes, and at telophase/cytokinesis Rap2 was
observed as puncta at the middle of the intercellular bridge, a position typically occupied by midbody associated factors. (B) Following
synchronization of cells as above, 80 mins. after nocodazole was washed-off samples were taken with four consecutive intervals of 10 minutes (I, II, III,
and IV), the last one (IV) corresponding to ,120 minutes after the drug was removed, and dynamic positioning of Rap2 at the intercellular bridge in
respect to a-tubulin was monitored. A time-dependent relocalization of Rap2 from peripheral flanking regions to the midbody was detected.
Intercellular bridge localizations of Rap2 were concluded with observations from a sample of ,50 cells in which over 75% showed similar positioning
patterns. Two sets of representative micrographs were displayed. Bars represent 10 mm.
doi:10.1371/journal.pone.0069289.g009
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Figure 10. Rap2 effector proteins translocate to the midbody depending on the signal transduction activity of Rap2. (A) HeLa cells
were transfected with the vector containing GFP-labeled Rap Binding Domain of RalGDS [GFP-RBD(RalGDS)] which interacts only with the GTP-bound
active form of Rap2, and cells were monitored at interphase and at cytokinetic abscission following immunostainings involving anti-Rap2 monoclonal
Abs and Alexa568-red labeled anti-mouse secondary Abs. Colocalization of GFP-RBD(RalGDS) with Rap2 indicated that at the midbody Rap2 is in its
active (Rap2.GTP) form. (B) HeLa cells were cotransfected with GFP-RBD(RalGDS) either together with HA-Rap2-WT, or with HA-Rap2-S17N (inactive
dominant negative form) and their localizations were monitored with anti-HA-epitope Abs. Positioning of GFP-RBD(RalGDS) were assessed by
monitoring GFP-signal observed at the midbody. Localization of the GFP-RBD(RalGDS) depended on the presence of active Rap2 in cells. As in (A), at
least 50 cells were monitored in each experiment, and representative pictures display Rap2 and GFP-RBD(RalGDS) localizations observed at least
,90% of cells cotransfected with indicated vectors. Bars represent 10 mm.
doi:10.1371/journal.pone.0069289.g010
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Immunoprecipitation, Immunoblotting and GST-Pull
Down Assays
Cells lysed in 50 ml lysis buffer consisting of 50 mM Tris 8.0
Base, 250 mM NaCl, proteinase inhibitor cocktail (Roche), and
1% NP40. Protein concentrations were determined by using
Bradford assay. 40 mg of whole cell extracts were denatured in gel
loading buffer [50 mM Tris-HCl pH 6.8, 1% SDS, 0.02%
bromophenol blue, 10% Glycerol and 5% 2-mercaptoethanol]
at 95uC for 5 min, resolved by SDS-PAGE using a 12% gel, and
electrotransferred onto PVDF membranes (Millipore). For Ras-
GEF1B/Ccdc124 coimmunoprecipitation experiments, HEK-293
cells were transfected with flag-Ccdc124 and YFP-RasGEF1B
vectors. 48 hours later, cells were lysed in NP-40 lysis buffer, flag-
tagged agarose beads (A2220, Sigma-Aldrich) were used to
precipitate proteins for two hours, followed by a centrifugation
for 30 sec. at 8800 rpm, then beads were washed three times with
NP-40 lysis buffer. 50 ml sample buffers were added to lysates and
incubated at 95uC for 5 min, fractionated by SDS-PAGE for
immunoblot analysis and transferred onto PVDF membranes
(Millipore). Anti-GFP (G1544, Sigma-Aldrich) and anti-Flag-HRP
M2 (A8592, Sigma-Aldrich) were used in Western blot analysis.
Blotted proteins were visualized using the ECL detection system
(Amersham). For GST pull-down assays, 100 ml 50% slurry
(,50 ml packed) GSH beads were washed 3 times with wash buffer
(50 mM Tris HCl pH 7.5, 100 mM NaCl, 3 mM b-Mercapto-
ethanol). First two vials were immobilized with 200 mg purified
GST-RasGEF1B protein, second vial was immobilized with
200 mg GST protein, whereas the fourth vial was incubated with
buffer only and rotated at 4uC for 1 hour. The first and the third
vials incubated with wash buffer only, second and fourth vials
incubated with 500 mg bacteria purified His-Ccdc124 protein and
incubated at 4uC for 1 hour by rotating. Beads were washed 10
times with wash buffer, and samples were eluted with 40 ml 4xSDS
loading buffer, boiled for 5 min and loaded on an SDS gel. For the
control of protein sizes samples from a 10 mg/ml stock of each
protein were loaded to the same gel. The gel then stained with
commassie blue and destained with water.
Generation of Polyclonal Antibodies
3 mg of N-terminus 24mer peptide MPKKFQGENTK-
SAAARARRAEAK-[C]-amide of human Ccdc124, and [C]-
NNMEKDR-W-KSLRSSLLNRT peptide corresponding to part-
ly conserved C-terminus of the zebra fish homologue of
RasGEF1B (Danio rerio RasGEF domain family member 1Ba,
NCBI accession number: NM_199829) were coupled to KLH
through their inserted cysteine residues via MBS, and Both
peptides were used in rabbit immunizations at the Cambridge
Research Biochemicals (Cambridge, United Kingdoms). 10 mg of
each peptide affinity column purified (Glycine and TEA eluates)
antibodies and pre-immune control sera were then received for use
in molecular biology research.
Immunofluorescence
HeLa cells on cover slips were fixed by ice cold 100% Methanol
for 10 min at 220uC, washed three times with PBS-T; blocked in
2% BSA for 1 hour and incubated 1 hour with primary antibodies,
washed again three times with PBS-T and incubated for 1 hour
with suitable secondary antibodies. Sources of antibodies: Plk1 a
gift from Nurhan Özlü, Koç University, Istanbul; monoclonal
(ab17057), or polyclonal (ab109777) Abs were purchased from
Abcam; anti-RasGEF1B-C-ter epitope Ab and anti-Ccdc124-N-
ter epitope Ab were custom produced by Cambridge Research
Biochemicals-UK (see above), Ccdc124 middle-epitope specific (A-
301-835A) or C-ter epitope specific (A-301-834A) Abs were from
BETHYL Laboratories; anti-c-tubulin were either from Abcam
(ab11316), or from BioLegend (rabbit polyclonal cat.620902); anti-
a-tubulin were from Santa Cruz (SC-5286); rabbit anti-flag-Ab
was from Sigma (F-7425); rabbit anti-Rap2 polyclonal was
purchased from Genetex (GTX108831); mouse anti-Rap2 mono-
clonal was from BD Biosciences (610215), DNA dye (DAPI) was
from Invitrogene (P36931); and Alexa Fluor 488, or 568 labeled
anti-rabbit, and anti-mouse secondary antibodies were purchased
from Invitrogene.
Fluorescent Microscopy and Imaging
Fluorescent images were done by Zeiss Imager-A1 microscope
with a Zeiss Acroplan 40X objective. Images were captured on the
Zeiss Axia Cam MRc 5-CCD camera for fixed samples.
Microscope control and image processing were done through
Axiovision version 4.6 software program (Universal Imaging).
Northern Blot Analysis
Northern blotting was performed on commercially obtained
‘‘FirstChoice Northern Human Blot-1 and Blot-2 Membranes’’
(Ambion) which contained 2 mg poly(A)-RNA from indicated
human organs on each lane. Donor information is available at the
suppliers (Ambion) documents; human derived materials have
been prepared in the mentioned company from tissues obtained
with consent from a fully informed donor, or a member of the
donor’s family, as certified by the company. DNA probes used in
hybridizations were as follows: ApaI-XbaI DNA fragment
(381 bp) of CCDC124 cut-out from Flag-Ccdc124 plasmid vector,
GAPDH fragment (408 bp) obtained after PCR amplification of a
HeLa cell cDNA library by using forward primer 59-GGCTGA-
GAACGGGAAGCTTGTCAT-39 and reverse primer 59-
CAGCCTTCTCCATGGTGGTGAAGA-39 as amplification
primers, and b-actin fragment (539 bp) obtained after PCR
amplification of the same cDNA library by using forward 59-
GATGACCCAGATCATGTTTG-39 and reverse 59- CATG-
GAGGAGCCGCCAGACAGC-39 primers in PCR amplifications
in the following conditions: 5 min initial denaturation at 95uC, 35
cycles of 30 sec denaturation at 95uC, 30 sec primer annealing at
60uC and 30 sec extension at 72uC, and a 5 min final extension at
72uC. Then, DNA templates corresponding to expected band sizes
were isolated from agarose gels, labeled by North-2-South Biotin
random prime labeling kit (Pierce). Nucleic acids hybridization
and detection were done by North-2-South Chemiluminescent
hybridization and detection kit (Pierce). Resulting blots were
exposed to autoradiography films (Kodak).
Identification of CCDC124-interacting Proteins by using
the Yeast Two-hybrid (Y2H) Screening Method
Bait cloning and Y2H screening were performed by Hybri-
genics, S.A., Paris, France (http://www.hybrigenics.com). Human
CCDC124 cDNA (encoding 223 a.a protein) was PCR-amplified
and cloned in a LexA C-terminal fusion vector. The bait construct
was checked by sequencing the entire insert, and was subsequently
transformed in the L40DGAL4 yeast strain [49]. Then, a human
liver cDNA library containing ten million independent fragments
were transformed into the Y187 yeast strain, which was used for
mating. The screen was performed in conditions ensuring a
minimum of 50 million interactions tested, in order to cover five
times the primary complexity of the yeast-transformed cDNA
library. After selection on medium lacking leucine, tryptophane,
and histidine, 15 positive clones were picked, and the correspond-
ing prey fragments were sequenced at their 59 and 39 junctions.
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Sequences were contigued as described previously, and then they
were compared to the latest release of the GenBank database using
BLASTN [50]. A Predicted Biological Score (PBS) was attributed
to assess the reliability of each interaction, as described previously
[51].
Supporting Information
Figure S1 Ccdc124 contains two main coiled-coil do-
mains at its N-terminal part. Schematic representation of the
coiled-coil prediction of Ccdc124 is presented. The graph was
obtained by the COILS (www.ch.embnet.org/software/
COILS_form.html) bioinformatics analysis platform.
(TIFF)
Figure S2 Double-thymidine and nocodazole treat-
ments synchronized HeLa cells at G2/M phase of cell
cycle. HeLa cells were treated with thymidine and MT
polymerization inhibitor drug nocodazole as indicated in Methods.
16106 unsynchronized (A) or synchronized (B) cells were
collected as samples, and resuspended in 0.3 ml of PBS buffer.
Cells were fixed by addition of 0.7 ml cold ethanol (70%), left on
ice for 1 hr, and then washed and resuspended in 0.25 ml of PBS
in which it is treated with 0.5 mg/ml RNAse-A for 1 hr at 37uC.
Cellular DNA is then stained with 10 mg/ml propidium iodide (PI)
solution, and cytometric analysis was performed by FACS at
488 nm. Percentages of cells in each sample at various stages of the
cell cycle are indicated below each panel (A–B).
(TIFF)
Figure S3 Polyclonal Anti-RasGEF1B antibody raised
against zebrafish homologue of RasGEF1B cross-reacts
strongly with human RasGEF1B. HEK-293 cells were
transfected with mCherry-labeled human RasGEF1B or YFP-
labeled human RasGEF1B expression vectors (mCherry-Ras-
GEF1B and YFP-RasGEF1B, respectively), after 48 hours cells
were lysed, proteins were separated by SDS-PAGE, and
immunoblot was performed with anti-RasGEF1B antibody alone
(1 mg at 1:1000 dilution), and then the membrane was stripped
and sequentially reprobed first with the same antibody pre-
incubated with 100 ng of competing 20mer peptide epitope [C]-
NNMEKDR-W-KSLRSSLLNRT corresponding to C-terminus
of ZF-RasGEF1B, and then with anti-GFP antibody recognizing
YFP as its epitope in YFP-RasGEF1B. Calnexin expression was
monitored as loading control.
(TIFF)
Figure S4 Screening of RasGEF1B specific shRNA
plasmids to monitor their down-regulatory capacities.
HEK-293 cells were transfected with RasGEF1B shRNA plasmids
described in Materials and MethodsS1. 48 hours after transfec-
tions, cells were lysed and proteins were separated by SDS-PAGE.
Immunoblot was performed with custom made anti-RasGEF1B
antibody. Image-J software program were used to obtain
densitometric readings of band intensities corrected by calnexin
values, and these were indicated below each band. RasGEF1B
specific shRNA expressing vector renamed as sh-D (see Materials
and Methods S1) was selected to carry-out experiments described in
Results. Calnexin expression was monitored as loading control.
(TIFF)
Figure S5 Endogenous Rap1 does not relocate to the
midzone/midbody during cytokinetic abscission. HeLa
cells were arrested at G2/M phase by sequential double thymidine
and nocodazole treatments as described in the legend of Figure 2,
and they were classified according to phases of mitosis, and
cytokinesis. Samples of cells were then costained with anti-Rap1
and anti-a-tubulin antibodies, which were used to monitor
intercellular bridge and the space containing midbody complexes.
DAPI staining was used to visualize DNA. Bars represent 10 mm.
(TIFF)
Figure S6 Mutating the consensus CK2 phosphorylation
site Ser122 to Ala leads to compromised stability of
Ccdc124. (A–B) HEK-293 cells were transfected either with HA-
tagged wild-type Ccdc124 expression vector, or with similar
vectors carrying indicated mutations on Figures, and stabilities of
mutants proteins were monitored by immunoblots using anti-
Ccdc124 antibodies recognizing the N-terminus of the protein.
Only one CK2 phosphorylation consensus site (Ser122) turned out
to be essential for the stability of Ccdc124 protein as S122A
mutants were cleaved at their C-terminus, whereas phospho-
mimicking mutations S121D, and S121E were normal in terms of
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5. Haren L, Stearns T, Lüders J (2009) Plk1-dependent recruitment of gamma-
tubulin complexes to mitotic centrosomes involves multiple PCM components.
PLoS ONE 4: e5976.
6. Schatten H, Sun QY (2010) The role of centrosomes in fertilization, cell division
and establishment of asymmetry during embryo development. Semin Cell Dev
Biol 21: 174–84.
7. Lee K, Rhee K (2011) PLK1 phosphorylation of pericentrin initiates centrosome
maturation at the onset of mitosis. J Cell Biol 195: 1093–101.
8. Jakobsen L, Vanselow K, Skogs M, Toyoda Y, Lundberg E, et al. (2011) Novel
asymmetrically localizing components of human centrosomes identified by
complementary proteomics methods. EMBO J 30: 1520–35.
9. Cohen C, Parry DA (1990) Alpha-helical coiled coils and bundles: how to design
an alpha-helical protein. Proteins 7: 1–15.
10. Fededa JP, Gerlich DW (2012) Molecular control of animal cell cytokinesis. Nat
Cell Biol 14: 440–7.
Ccdc124 Is Involved in Cytokinesis
PLOS ONE | www.plosone.org 16 July 2013 | Volume 8 | Issue 7 | e69289
11. Gromley A, Yeaman C, Rosa J, Redick S, Chen CT, et al. (2005) Centriolin
anchoring of exocyst and SNARE complexes at the midbody is required for
secretory-vesicle-mediated abscission. Cell 123: 75–87.
12. Skop AR, Liu H, Yates J, Meyer BJ, Heald R (2004) Dissection of the
mammalian midbody proteome reveals conserved cytokinesis mechanisms.
Science 305: 61–6.
13. Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, et al. (2005) Cdk1/Erk2-
and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is
required for its recruitment to midbody and cytokinesis. Dev Cell 9: 477–88.
14. van der Horst A, Simmons J, Khanna KK (2009) Cep55 stabilization is required
for normal execution of cytokinesis. Cell Cycle 8: 3742–9.
15. Lee HH, Elia N, Ghirlando R, Lippincott-Schwartz J, Hurley JH (2008)
Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in
CEP55. Science 322: 576–80.
16. Hu CK, Coughlin M, Mitchison TJ (2012) Midbody assembly and its regulation
during cytokinesis. Mol Biol Cell 23: 1024–34.
17. Carlton JG, Martin-Serrano J (2007) Parallels between cytokinesis and retroviral
budding: a role for the ESCRT machinery. Science 316: 1908–12.
18. Guizetti J, Schermelleh L, Mantler J, Maar S, Poser I, et al. (2011) Cortical
constriction during abscission involves helices of ESCRT-III-dependent
filaments. Science 331: 1616–20.
19. Hanson PI, Roth R, Lin Y, Heuser JE (2008) Plasma membrane deformation by
circular arrays of ESCRT-III protein filaments. J Cell Biol 180: 389–402.
20. Elia N, Sougrat R, Spurlin TA, Hurley JH, Lippincott-Schwartz J (2011)
Dynamics of endosomal sorting complex required for transport (ESCRT)
machinery during cytokinesis and its role in abscission. Proc. Natl Acad Sci USA
108: 4846–51.
21. Lane HA, Nigg EA (1996) Antibody microinjection reveals an essential role for
human polo-like kinase 1 (Plk1) in the functional maturation of mitotic
centrosomes. J Cell Biol 135: 1701–13.
22. Tong C, Fan HY, Lian L, Li SW, Chen DY, et al. (2002) Polo-like kinase-1 is a
pivotal regulator of microtubule assembly during mouse oocyte meiotic
maturation, fertilization, and early embryonic mitosis. Biol Reprod 67: 546–54.
23. Bastos RN, Barr FA (2010) Plk1 negatively regulates Cep55 recruitment to the
midbody to ensure orderly abscission. J Cell Biol 191: 751–60.
24. Yaman E, Gasper R, Koerner C, Wittinghofer A, Tazebay UH (2009)
RasGEF1A and RasGEF1B are guanine nucleotide exchange factors that
discriminate between Rap GTP-binding proteins and mediate Rap2-specific
nucleotide exchange. FEBS J 276: 4607–16.
25. Gloerich M, Bos JL (2011) Regulating Rap small G-proteins in time and space.
Trends Cell Biol 21: 615–23.
26. Uetake Y, Loncarek J, Nordberg JJ, English CN, La Terra S, et al. (2007) Cell
cycle progression and de novo centriole assembly after centrosomal removal in
untransformed human cells. J Cell Biol 176: 173–82.
27. Gromley A, Jurczyk A, Sillibourne J, Halilovic E, Mogensen M, et al. (2003) A
novel human protein of the maternal centriole is required for the final stages of
cytokinesis and entry into S phase. J Cell Biol 161: 535–45.
28. Epting D, Vorwerk S, Hageman A, Meyer D (2007) Expression of rasgef1b in
zebrafish. Gene Expr Patterns 7: 389–95.
29. Andrade WA, Silva AM, Alves VS, Salgado AP, Melo MB, et al. (2010) Early
endosome localization and activity of RasGEF1b, a toll-like receptor-inducible
Ras guanine-nucleotide exchange factor. Genes Immun 11: 447–57.
30. Schiel JA, Prekeris R (2013) Membrane dynamics during cytokinesis. Curr.
Opin. in Cell. Biol 25: 92–8.
31. van Triest M, Bos JL (2004) Pull-down assays for guanoside 59-triphosphate-
bound Ras-like guanosine 59-triphosphatases. Methods Mol Biol 250: 97–102.
32. Bivona TG, Wiener HH, Ahearn IM, Silletti J, Chiu VK, et al. (2004) Rap1 up-
regulation and activation on plasma membrane regulates T cell adhesion. J Cell
Biol 164: 461–70.
33. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, et al. (1998)
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic
AMP. Nature 396: 474–7.
34. Ghandour H, Cullere X, Alvarez A, Luscinskas FW, Mayadas TN (2007)
Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI
in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion. Blood 110:
3682–90.
35. Stearns T, Winey M (1997) The Cell Center at 100. Cell 91: 303–9.
36. Piel M, Nordberg J, Euteneuer U, Bornens M (2001) Centrosome-dependent
exit of cytokinesis in animal cells. Science 291: 1550–3.
37. Oakley BR, Oakley CE, Yoon Y, Jung MK (1990) Gamma-tubulin is a
component of the spindle pole body that is essential for microtubule function in
Aspergillus nidulans. Cell 61: 1289–301.
38. Morita E, Sandrin V, Chung HY, Morham SG, Gygi SP, et al. (2007) Human
ESCRT and ALIX proteins interact with proteins of the midbody and function
in cytokinesis. EMBO J 26: 4215–27.
39. Steigemann P, Gerlich DW (2009) Cytokinetic abscission: cellular dynamics at
the midbody. Trends Cell Biol 19: 606–16.
40. Schiel JA, Childs C, Prekeris R (2013) Endocytic transport and cytokinesis: from
regulation of the cytoskeleton to midbody inheritence Trends Cell Biol (in press,
http://dx.doi.org/10.1016/j.tcb.2013.02.003).
41. Cascone I, Selimoglu R, Ozdemir C, Del Nery E, Yeaman C, et al. (2008)
Distinct roles of RalA and RalB in the progression of cytokinesis are supported
by distinct RalGEFs. EMBO J 27: 2375–87.
42. Dambournet D, Machicoane M, Chesneau L, Sachse M, Rocancourt M, et al.
(2011) Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for
successful cytokinesis. Nat Cell Biol 13: 981–8.
43. Sagona AP, Nezis IP, Pedersen NM, Liestol K, Poulton J, et al. (2010) PtdIns(3)P
controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to
the midbody. Nat Cell Biol 12: 362–71.
44. Choi SC, Kim GH, Lee SJ, Park E, Yeo CY, et al. (2008) Regulation of activin/
nodal signaling by Rap2-directed receptor trafficking. Dev Cell 15: 49–61.
45. Schiel JA, Simon GC, Zaharris C, Weisz J, Castle D, et al. (2012) FIP3-
endosome-dependent formation of the secondary ingression mediates ESCRT-
III recruitment during cytokinesis. Nat Cell Biol 14: 1068–78.
46. Gloerich M, Ponsioen B, Vliem MJ, Zhang Z, Zhao J, et al. (2010) Spatial
regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins.
Mol Cell Biol 30: 5421–31.
47. Burkard ME, Randall CL, Larochelle S, Zhang C, Shokat KM, et al. (2007)
Chemical genetics reveals the requirement for Polo-like kinase 1 activity in
positioning RhoA and triggering cytokinesis in human cells. Proc. Natl Acad Sci
USA 104: 4383–8.
48. Paddison PJ, Cleary M, Silva JM, Chang K, Sheth N, et al. (2004) Cloning of
short hairpin RNAs for gene knock-down in mammalian cells. Nat Methods 1:
163–167.
49. Fromont-Racine M, Rain JC, Legrain P (1997) Toward a functional analysis of
the yeast genome through exhaustive two-hybrid screens. Nat Genet 16: 277–82.
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